
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI
[ Tue, Feb 13th 2018 ]: WOPRAI

[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI

[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
Vamil Divan Maintained (TEVA) at Buy with Increased Target to $23 on, Feb 12th, 2018


🞛 This publication is a summary or evaluation of another publication
Vamil Divan of Credit Suisse, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Buy with Increased Target from $20 to $23 on, Feb 12th, 2018.
Vamil has made no other calls on TEVA in the last 4 months.
There are 13 other peers that have a rating on TEVA. Out of the 13 peers that are also analyzing TEVA, 5 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Gregg Gilbert of "Deutsche Bank" Maintained at Hold with Decreased Target to $18 on, Friday, February 9th, 2018
- Tim Chiang of "BTIG" Downgraded from Strong Buy to Hold on, Thursday, January 18th, 2018
- David Risinger of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, December 15th, 2017
- Rohit Vanjani of "Guggenheim" Initiated at Hold and Held Target at $16 on, Tuesday, December 12th, 2017
- Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $19 on, Friday, October 20th, 2017
These are the ratings of the 8 analyists that currently disagree with Vamil
- Ami Fadia of "Leerink Swann" Maintained at Sell with Decreased Target to $16 on, Friday, February 9th, 2018
- David Amsellem of "Piper Sandler" Downgraded from Hold to Sell on, Friday, February 9th, 2018
- Jason Gerberry of "B of A Securities" Maintained at Sell with Decreased Target to $16 on, Friday, February 9th, 2018
- Irina Rivkind Koffler of "Mizuho" Upgraded from Hold to Strong Buy on, Tuesday, January 9th, 2018
- Jacob Hughes of "Wells Fargo" Downgraded from Hold to Sell on, Friday, January 5th, 2018
- Liav Abraham of "Citigroup" Upgraded from Hold to Strong Buy on, Thursday, January 4th, 2018
- Jami Rubin of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Friday, December 15th, 2017
- Chris Schott of "JP Morgan" Downgraded from Hold to Sell on, Monday, November 13th, 2017
Similar Stocks and Investing Publications
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Thu, Jan 18th 2018 ]: WOPRAI
[ Tue, Jan 09th 2018 ]: WOPRAI
[ Fri, Jan 05th 2018 ]: WOPRAI
[ Thu, Jan 04th 2018 ]: WOPRAI
[ Tue, Jan 02nd 2018 ]: WOPRAI
[ Fri, Dec 15th 2017 ]: WOPRAI
[ Fri, Dec 15th 2017 ]: WOPRAI
[ Tue, Dec 12th 2017 ]: WOPRAI